Imugene (ASX:IMU) said it will seek shareholder approval in June for a 34-to-1 share consolidation, reducing its share count from 7.47 billion to about 219.6 million, according to a Friday filing with the Australian bourse.
The company said the move is expected to lift the stock's trading price.
Shares of the company fell 2% in recent Friday trade.